Best Biotech Stocks to Buy Now (2024)Top biotech stocks in 2024 ranked by overall Zen Score. See the best biotech stocks to buy now, according to analyst forecasts for the biotechnology industry.
Industry: Biotechnology
| Ticker | Company | Country | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|
| SNGX | SOLIGENIX INC | United States | $4.37M | 10,524,437 | 0.36% | 99.64% | ||
| ADVM | ADVERUM BIOTECHNOLOGIES INC | United States | $190.74M | 20,754,915 | 72.30% | 27.70% | Net Buying | Net Buying |
| BHVN | BIOHAVEN LTD | United States | $3.18B | 81,579,914 | 79.08% | 20.92% | Net Buying | Net Buying |
| TOVX | THERIVA BIOLOGICS INC | United States | $7.19M | 17,148,049 | 6.14% | 1.46% | Net Buying | |
| TPST | TEMPEST THERAPEUTICS INC | United States | $78.56M | 22,192,026 | 4.15% | 95.85% | ||
| AIM | AIM IMMUNOTECH INC | United States | $21.36M | 49,901,177 | 8.32% | 9.92% | Net Buying | Net Buying |
| ALNY | ALNYLAM PHARMACEUTICALS INC | United States | $18.05B | 125,945,793 | 80.88% | 19.12% | Net Selling | Net Selling |
| XLO | XILIO THERAPEUTICS INC | United States | $37.58M | 34,473,486 | 37.10% | 62.90% | Net Buying | Net Buying |
| INBX | INHIBRX INC | United States | $1.61B | 47,392,447 | 72.56% | 27.44% | Net Buying | |
| PIRS | PIERIS PHARMACEUTICALS INC | United States | $14.49M | 1,236,688 | 89.20% | 10.80% | Net Buying | |
| CERE | CEREVEL THERAPEUTICS HOLDINGS INC | United States | $7.71B | 181,576,482 | 26.94% | 73.06% | Net Buying | Net Selling |
| REVB | REVELATION BIOSCIENCES INC | United States | $3.56M | 1,632,935 | 8.80% | 91.20% | Net Selling | |
| PROK | PROKIDNEY CORP | United States | $486.21M | 229,343,531 | 12.81% | 8.98% | Net Selling | Net Selling |
| CGTX | COGNITION THERAPEUTICS INC | United States | $76.05M | 39,000,152 | 18.34% | 62.09% | Net Buying | Net Selling |
| CKPT | CHECKPOINT THERAPEUTICS INC | United States | $51.03M | 35,686,279 | 13.69% | 8.02% | Net Selling | Net Selling |
| PTCT | PTC THERAPEUTICS INC | United States | $2.19B | 76,696,785 | 85.74% | 14.26% | Net Selling | Net Selling |
| CGEN | COMPUGEN LTD | Israel | $169.76M | 88,415,382 | 11.98% | 0.00% | ||
| CDMO | AVID BIOSERVICES INC | United States | $466.58M | 63,479,794 | 90.14% | 9.06% | Net Selling | |
| MCRB | SERES THERAPEUTICS INC | United States | $124.58M | 151,009,462 | 59.28% | 30.14% | Net Selling | Net Selling |
| TRVN | TREVENA INC | United States | $7.16M | 18,321,010 | 7.63% | 92.37% | Net Buying | |
| CELU | CELULARITY INC | United States | $58.52M | 19,378,164 | 5.49% | 94.51% | Net Buying | Net Selling |
| GYRE | GYRE THERAPEUTICS INC | United States | $1.46B | 85,423,246 | 0.37% | 99.63% | Net Buying | Net Buying |
| CYTK | CYTOKINETICS INC | United States | $6.73B | 103,004,710 | 88.31% | 11.69% | Net Selling | Net Selling |
| KYTX | KYVERNA THERAPEUTICS INC | United States | $666.99M | 43,115,244 | 0.00% | 51.65% | Net Buying | Net Buying |
| OGEN | ORAGENICS INC | United States | $4.62M | 4,480,693 | 0.16% | 99.84% | Net Selling | |
| SMMT | SUMMIT THERAPEUTICS INC | United Kingdom | $2.71B | 701,697,179 | 4.61% | 92.95% | Net Buying | Net Buying |
| PXMD | PAXMEDICA INC | United States | $5.48M | 7,408,067 | 1.39% | 98.61% | Net Selling | Net Selling |
| COEP | COEPTIS THERAPEUTICS HOLDINGS INC | United States | $12.09M | 36,089,917 | 13.11% | 41.01% | Net Buying | |
| NBSE | NEUBASE THERAPEUTICS INC | United States | $1.64M | 3,729,206 | 3.93% | 96.07% | Net Selling | |
| PRTG | PORTAGE BIOTECH INC | Canada | $4.75M | 19,778,000 | 11.46% | 0.00% | ||
| VSTM | VERASTEM INC | United States | $237.27M | 25,295,495 | 25.42% | 74.58% | Net Selling | Net Selling |
| PHIO | PHIO PHARMACEUTICALS CORP | United States | $3.13M | 4,591,700 | 0.49% | 99.51% | Net Buying | Net Selling |
| CDXS | CODEXIS INC | United States | $187.01M | 70,303,639 | 46.84% | 53.16% | Net Buying | |
| ATXI | AVENUE THERAPEUTICS INC | United States | $3.66M | 590,142 | 4.45% | 95.55% | Net Buying | |
| IMNN | IMUNON INC | United States | $13.54M | 9,399,789 | 4.47% | 92.02% | ||
| NAMS | NEWAMSTERDAM PHARMA CO NV | Netherlands | $1.96B | 89,266,673 | 60.05% | 39.95% | Net Selling | Net Selling |
| KALV | KALVISTA PHARMACEUTICALS INC | United States | $454.79M | 42,188,296 | 48.19% | 51.81% | Net Buying | Net Selling |
| VANI | VIVANI MEDICAL INC | United States | $89.61M | 54,978,000 | 2.51% | 97.49% | Net Buying | Net Buying |
| CYBN | CYBIN INC | Canada | $143.93M | 411,216,132 | 13.89% | 0.00% | ||
| NBY | NOVABAY PHARMACEUTICALS INC | United States | $2.38M | 30,098,150 | 1.80% | 98.20% | ||
| TIL | INSTIL BIO INC | United States | $68.94M | 6,503,913 | 4.92% | 95.08% | ||
| MNPR | MONOPAR THERAPEUTICS | United States | $11.49M | 17,454,925 | 1.40% | 98.60% | Net Selling | Net Selling |
| AVBP | ARRIVENT BIOPHARMA INC | United States | $471.97M | 30,567,768 | 0.00% | 34.25% | Net Buying | Net Buying |
| BIOR | BIORA THERAPEUTICS INC | United States | $19.04M | 30,313,428 | 10.45% | 89.55% | Net Selling | |
| BCDA | BIOCARDIA INC | United States | $10.08M | 26,732,542 | 1.04% | 98.96% | Net Buying | Net Buying |
| INDP | INDAPTUS THERAPEUTICS INC | Israel | $18.02M | 8,538,883 | 7.05% | 84.59% | Net Buying | |
| SAVA | CASSAVA SCIENCES INC | United States | $965.65M | 43,225,211 | 28.44% | 71.56% | Net Buying | Net Buying |
| FBLG | FIBROBIOLOGICS INC | United States | $329.93M | 32,634,366 | 0.00% | 0.39% | ||
| ANRO | ALTO NEUROSCIENCE INC | United States | $381.21M | 26,883,988 | 0.00% | 24.97% | Net Buying | Net Buying |
| NVCT | NUVECTIS PHARMA INC | United States | $115.50M | 17,768,824 | 8.52% | 50.88% | Net Buying | Net Buying |
| ELEV | ELEVATION ONCOLOGY INC | United States | $176.12M | 48,651,115 | 53.13% | 24.22% | Net Selling | Net Selling |
| APLM | APOLLOMICS INC | United States | $40.27M | 89,495,790 | 9.89% | 0.00% | ||
| CALC | CALCIMEDICA INC | United States | $58.53M | 10,740,115 | 2.26% | 97.74% | Net Buying | Net Buying |
| XRTX | XORTX THERAPEUTICS INC | Canada | $5.86M | 1,998,848 | 100.00% | 0.00% | ||
| CARA | CARA THERAPEUTICS INC | United States | $37.38M | 54,656,413 | 44.64% | 53.42% | Net Selling | Net Selling |
| ESLA | ESTRELLA IMMUNOPHARMA INC | United States | $37.34M | 36,610,870 | 0.35% | 80.34% | Net Selling | |
| INAB | IN8BIO INC | United States | $45.02M | 43,287,325 | 19.83% | 52.04% | Net Buying | |
| MNMD | MIND MEDICINE (MINDMED) INC | Canada | $352.17M | 41,334,307 | 10.01% | 89.99% | Net Selling | Net Selling |
| KOD | KODIAK SCIENCES INC | United States | $172.23M | 52,508,602 | 67.33% | 32.67% | Net Selling | |
| NEXI | NEXIMMUNE INC | United States | $4.62M | 1,371,051 | 1.34% | 98.66% | Net Selling | |
| BOLD | BOUNDLESS BIO INC | United States | N/A | 22,239,333 | 0.00% | 23.98% | Net Buying | Net Buying |
| LIXT | LIXTE BIOTECHNOLOGY HOLDINGS INC | United States | $7.33M | 2,249,290 | 2.04% | 97.96% | Net Buying | |
| CNTX | CONTEXT THERAPEUTICS INC | United States | $22.51M | 15,966,053 | 22.29% | 7.22% | ||
| ASMB | ASSEMBLY BIOSCIENCES INC | United States | $69.36M | 5,482,752 | 23.35% | 76.65% | Net Buying | Net Selling |
| ANL | ADLAI NORTYE LTD | United States | $506.87M | 110,700,805 | 0.06% | 0.00% | ||
| LCTX | LINEAGE CELL THERAPEUTICS INC | United States | $214.93M | 188,533,536 | 34.36% | 65.64% | Net Buying | Net Buying |
| SCPX | SCORPIUS HOLDINGS INC | United States | $6.09M | 36,031,964 | 4.71% | 17.31% | ||
| IMUX | IMMUNIC INC | Germany | $109.71M | 89,929,016 | 16.47% | 17.18% | Net Buying | Net Buying |
| ALRN | AILERON THERAPEUTICS INC | United States | $84.86M | 16,972,512 | 3.39% | 96.61% | Net Buying | |
| ADXN | ADDEX THERAPEUTICS LTD | Switzerland | $16.13M | 125,195,393 | 0.13% | 0.00% | ||
| AKBA | AKEBIA THERAPEUTICS INC | United States | $280.56M | 209,372,275 | 26.15% | 8.85% | Net Selling | Net Selling |
| VERA | VERA THERAPEUTICS INC | United States | $2.16B | 54,452,029 | 55.23% | 44.77% | Net Selling | Net Selling |
| KZIA | KAZIA THERAPEUTICS LTD | Australia | $9.75M | 263,615,444 | 1.85% | 8.44% | ||
| MDGL | MADRIGAL PHARMACEUTICALS INC | United States | $3.85B | 19,897,425 | 22.67% | 77.33% | Net Buying | Net Buying |
| AGEN | AGENUS INC | United States | $244.86M | 20,946,004 | 63.15% | 36.85% | Net Buying | Net Buying |
| VAXX | VAXXINITY INC | United States | $14.83M | 126,747,684 | 4.14% | 95.86% | Net Selling | |
| TSVT | 2SEVENTY BIO INC | United States | $218.33M | 51,311,132 | 65.20% | 34.80% | Net Buying | Net Buying |
| AVTX | AVALO THERAPEUTICS INC | United States | $16.48M | 1,034,130 | 0.03% | 99.97% | Net Selling | |
| GUTS | FRACTYL HEALTH INC | United States | $320.78M | 47,878,269 | 0.00% | 59.98% | Net Buying | Net Buying |
| OMER | OMEROS CORP | United States | $182.52M | 57,942,695 | 43.03% | 6.69% | Net Buying | |
| EVAX | EVAXION BIOTECH A | Denmark | $15.84M | 37,897,780 | 1.18% | 0.00% | ||
| FGEN | FIBROGEN INC | United States | $102.72M | 98,771,247 | 70.94% | 12.66% | Net Selling | Net Selling |
| BBIO | BRIDGEBIO PHARMA INC | United States | $4.37B | 175,831,536 | 55.86% | 44.14% | Net Selling | Net Selling |
| NTRB | NUTRIBAND INC | United States | $27.81M | 7,833,150 | 2.49% | 72.38% | ||
| DARE | DARE BIOSCIENCE INC | United States | $30.78M | 100,581,900 | 6.57% | 25.43% | ||
| CERO | CERO THERAPEUTICS HOLDINGS INC | United States | $20.17M | 14,723,565 | 5.67% | 22.11% | ||
| NCNA | NUCANA PLC | United Kingdom | $8.46M | 52,860,335 | 29.52% | 0.00% | ||
| GRI | GRI BIO INC | United States | $1.37M | 3,196,488 | 6.80% | 86.05% | ||
| SANA | SANA BIOTECHNOLOGY INC | United States | $1.92B | 220,447,557 | 47.20% | 52.80% | Net Buying | Net Buying |
| CTCX | CARMELL CORP | United States | $40.22M | 19,245,248 | 11.98% | 59.11% | Net Buying | |
| PHGE | BIOMX INC | United States | $19.33M | 55,220,077 | 14.70% | 48.14% | Net Buying | |
| ARWR | ARROWHEAD PHARMACEUTICALS INC | United States | $2.74B | 123,896,914 | 62.55% | 10.70% | Net Selling | Net Selling |
| BIVI | BIOVIE INC | United States | $19.34M | 39,871,098 | 3.68% | 96.32% | Net Selling | |
| MBIO | MUSTANG BIO INC | United States | $3.28M | 10,390,132 | 9.95% | 24.56% | ||
| LBPH | LONGBOARD PHARMACEUTICALS INC | United States | $710.26M | 36,017,249 | 45.89% | 0.09% | Net Selling | |
| ITRM | ITERUM THERAPEUTICS PLC | Ireland | $27.43M | 16,426,784 | 1.70% | 98.30% | Net Buying | |
| WINT | WINDTREE THERAPEUTICS INC | United States | $2.67M | 510,179 | 0.28% | 99.72% | Net Buying | |
| RNAZ | TRANSCODE THERAPEUTICS INC | United States | $3.19M | 5,808,053 | 12.47% | 59.74% | Net Buying | |
| VINC | VINCERX PHARMA INC | United States | $15.63M | 21,413,389 | 45.80% | 53.71% | Net Buying | |
| PMN | PROMIS NEUROSCIENCES INC | Canada | $37.54M | 18,961,116 | 17.66% | 24.49% |
Biotech Stocks FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.